Metabolic Pathways of Leishmania Parasite: Source of Pertinent Drug Targets and Potent Drug Candidates

S Jain, U Sahu, A Kumar, P Khare - Pharmaceutics, 2022 - mdpi.com
Leishmaniasis is a tropical disease caused by a protozoan parasite Leishmania that is
transmitted via infected female sandflies. At present, leishmaniasis treatment mainly counts …

Drug associations as alternative and complementary therapy for neglected tropical diseases

LRM Ferraz, LCPBB Silva, ML de Souza, LP Alves… - Acta Tropica, 2022 - Elsevier
The present paper aims to establish different treatments for neglected tropical disease by a
survey on drug conjugations and possible fixed-dose combinations (FDC) used to obtain …

A new oral self-emulsifying drug delivery system improves the antileishmania efficacy of fexinidazole in vivo

DS do Nascimento Damasio, PA Antunes… - International Journal of …, 2023 - Elsevier
The aim of this study was to develop, characterize and evaluate the in vivo oral efficacy of
self-emulsifying drug delivery systems (SEDDS) containing fexinidazole (FEX) in the …

Repurposing of conformationally-restricted cyclopentane-based AKT–inhibitors leads to discovery of potential and more selective antileishmanial agents than …

AHE Hassan, MM Alam, TN Phan, KH Baek, H Lee… - Bioorganic …, 2023 - Elsevier
Conformational restriction was addressed towards the development of more selective and
effective antileishmanial agents than currently used drugs for treatment of Leishmania …

New amides containing selenium as potent leishmanicidal agents targeting trypanothione reductase

M Etxebeste-Mitxeltorena, D Plano… - Antimicrobial agents …, 2020 - Am Soc Microbiol
Two new series of 28 selenocyanate and diselenide derivatives containing amide moieties
were designed, synthesized, and evaluated for their leishmanicidal activity against …

Pharmacotherapy in leishmaniasis: Old, new treatments, their impacts and expert opinion

RNR Sampaio - Expert Opinion on Pharmacotherapy, 2023 - Taylor & Francis
Leishmaniasis is caused by protozoan parasites of the genus Leishmania. An estimated 20
different Leishmania species, each with a particular drug response, are associated with …

Leishmania LiHyC protein is immunogenic and induces protection against visceral leishmaniasis

AS Machado, DP Lage, DL Vale, CS Freitas… - Parasite …, 2022 - Wiley Online Library
Abstract Treatment against visceral leishmaniasis (VL) presents problems by the toxicity of
drugs, high cost and/or emergence of resistant strains. The diagnosis is hampered by …

A review on the drug delivery strategies for parasitic infections: scope and assertion

M Bhatia, S Kumar, A Kapoor, S Lohan - Drug Delivery Letters, 2022 - ingentaconnect.com
Parasitic infections are prime causes of morbidity and mortality worldwide. Significant
progress has been made to cure these infections, such as discovering antiparasitic drugs …

Phospholipid analogues as chemotherapeutic agents against trypanosomatids

E Chazapi, GE Magoulas, KC Prousis… - Current …, 2021 - ingentaconnect.com
Background: Neglected tropical diseases (NTDs) represent a serious problem in a number
of countries around the world and especially in Africa and South America, affecting mostly …

The Burden of Visceral Leishmaniasis: Need of Review, Innovations, and Solutions

I Farooq, R Singh, A Selvapandiyan… - Challenges and Solutions …, 2024 - Springer
Leishmaniasis is an ongoing public health crisis and asks for unabated addressal by all
stakeholders. Efforts to eradicate the disease have been underway for over a decade. While …